FindTrial
Sign In

Immunoprophylactic failure against hepatitis B virus mother-to-infant transmission from 2018 to 2023

Immunoprophylactic failure against hepatitis B virus mother to infant transmission from 2018 to 2023

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240401001
Enrollment
500
Registered
2024-04-01
Start date
2022-02-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mater to child viral hepatitis B transmission MTCT, HBV

Interventions

Children of hepatitis B surface antigenseropositive mothers with positive HBeAg status ,Children of hepatitis B surface antigen seropositive mothers with negative HBeAg status
Diagnostic,Diagnostic
Mother with positive HBeAg status ,Mother with negativeHBeAg status

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
1 Hours to 6 Months

Inclusion criteria

Inclusion criteria: All children of hepatitis B surface antigen (HBsAg) seropositive mothers with known HBeAg status

Exclusion criteria

Exclusion criteria: children of hepatitis B surface antigen (HBsAg) seropositive mothers with unknown HBeAg status

Design outcomes

Primary

MeasureTime frame
the prevalence and factors associated with the failure of immunoprophylactic Hepatitis B vaccines. 5 years Hepatitis B virology of the child measurment at 9-12 months—

Secondary

MeasureTime frame
N/A N/A N/A—

Countries

Thailand

Contacts

Public ContactBusara Charoenwat

Khonkaen University

busarcha@kku.ac.th0617923591

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026